Science Applications International Corporation · NASDAQ:SAIC
Science Applications International — Q4 FY2022 Earnings Presentation
20 slides from Science Applications International's earnings presentation, Mar 28, 2022
Slide 1: Fiscal Year 2022 Fourth Quarter Earnings Call
Science Applications International Corporation Fiscal Year 2022 Fourth Quarter Earnings Call Supplemental Financial Presentation March 28, 2022
Slide 2: Bring On Tomorrow
SAIC. BRING ON TOMORROVV, We're not just another company that solves problems. No, we're a company that never stops reaching. Never stops pushing beyond our limits. To rethink engineering in a digital world, we reached. To redefine space training through virtual reality, we reached. To redesign new
Slide 3: Forward Looking Statement
Forward Looking Statement Certain statements in this presentation are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “should,” “expects,” “intends,” “projects,” “plans,” “believes,” “estimates,” “targets,” “antici
Slide 4: Today's Presenters
Today’s Presenters Nazzic Keene Prabu Natarajan Chief Executive Officer Chief Financial Officer SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED I 4
Slide 5: SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED
SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED I 5
Slide 6: FY2022 & FY2023 Highlights
FY2022 & FY2023 Highlights Solid Organic Revenue Growth Strong Profitability Q4 Total Revenue Growth of ~4%, Organic Growth of 1.4% Q4 Adjusted EBITDA Margin * of 8.2% FY22 Total Revenue Growth of ~5%, Organic Growth of 2.5% FY22 Adjusted EBITDA Margin* of 9.3% Plan to reduce total share count by ~8
Slide 7: FY2022 Q4 Results
(1) FY2022 Q4 Results ADJUSTED ADJUSTED REVENUE FREE CASH FLOW (2) EBITDA MARGIN (2)(3) DILUTED EPS (2)(4) +4% total -110 bps -10% +74% +1.4% organic $94M 9.3% $1,782M 8.2% $1,717M $1.67 $54M $1.50 FY2021 FY2022 FY2021 FY2022 FY2021 FY2022 FY2021 FY2022 Q4 Q4 Q4 Q4 Q4 Q4 Q4 Q4 (1) Results of Science
Slide 8: FY2022 Results
(1) FY2022 Results ADJUSTED ADJUSTED REVENUE FREE CASH FLOW (2) EBITDA MARGIN (2)(3) DILUTED EPS (2)(4) +5% total +10% excl. FY21 one-time items +40 bps +16% +2.5% organic 8.9% 9.3% $7,394M $524M $7.27 $7,056M $467M $6.27 FY2021 FY2022 FY2021 FY2022 FY2021 FY2022 FY2021 FY2022 (1) Results of Science
Slide 9: Fiscal Year 2023 Guidance
Fiscal Year 2023 Guidance Current Revenue $7.35B - $7.55B New business, on-contract, and acquired revenue growth offset by contract transitions * Adjusted EBITDA % ~8.9% Reflects continued, strong operating performance * Effective tax rate ~ 24% Adjusted Diluted EPS $6.80 - $7.10 Interest ex
Slide 10: FY22 to FY23 Revenue Bridge
FY22 to FY23 Revenue Bridge $7,450 $7,394 +1% to +3.5% -3% to -4% +2% FY22 Actual Contract Halfaker + New Business & FY23 Mid-point Revenue Transitions Extra Working On Contract Of Revenue Days Growth Guidance New business, program additions and extra week offset headwinds from recent losses SAIC PR
Slide 11: FY21 to FY23 Adjusted EBITDA Margin Bridge
FY21 to FY23 Adjusted EBITDA Margin Bridge 0.4% 0.4% 8.9% ~8.9% 0.2% 0.2% 9.3% 8.9% 8.7% FY21 One-Time FY21 Improved One-Time FY22 One- FY22 FY23 Reported Items Adjusted Operating Gains Reported time Adjusted Guidance Performance Gains Guidance reflects continued strong operating performance and app
Slide 12: Total Backlog ($ in billions)
SAIC Historical Backlog and Book-to-Bill $25 2.2x 0.9x 1.2x 0.7x 2.7x 0.4x $20 Total Backlog ($ in billions) 2.6x 0.9x 1.5x $15 1.2x 1.4x 0.8x 0.9x 1.4x 1.0x 0.8x $10 $5 $0 FY19 Q1 FY19 Q2 FY19 Q3 FY19 Q4 FY20 Q1 FY20 Q2 FY20 Q3 FY20 Q4 FY21 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY22 Q1 FY22 Q2 FY22 Q3 FY22 Q4
Slide 13: Appendix
Appendix
Slide 14: Working Days Per Quarter
Working Days Per Quarter Q1 Q2 Q3 Q4 Total FY23 64 62 63 65 254 FY22 64 63 63 60 250 FY21 64 63 63 60 250 FY20 64 63 63 60 250 FY19 64 63 63 60 250 SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED I 14
Slide 15: Payroll Periods Per Quarter
Payroll Periods Per Quarter Q1 Q2 Q3 Q4 Total FY23 6 7 6 7 26 FY22 6 7 6 7 26 FY21 6 7 6 7 26 FY20 6 7 6.5* 7 26 FY19 6 7 6 7 26 *During the third quarter of fiscal year 2020 and as a result of a systems conversion due to the Engility acquisition, legacy Engility employees were paid a one week payro
Slide 16: Non-GAAP Reconciliation – EBITDA and Adjusted EBITDA
Non-GAAP Reconciliation – EBITDA and Adjusted EBITDA (1) EBITDA is a performance measure that is calculated by taking net income and excluding interest and loss on sale of receivables, provision for income taxes, and depreciation and amortization. Adjusted EBITDA and adjusted operating income are pe
Slide 17: Non-GAAP Reconciliation – Adjusted Diluted Earnings per Share
Non-GAAP Reconciliation – Adjusted Diluted Earnings per Share (1) Adjusted diluted earnings per share is a performance measure that excludes acquisition and integration costs, impairments, restructuring costs, and any other material non-recurring costs that we do not consider to be indicative of our
Slide 18: Non-GAAP Reconciliation – Free Cash Flow
Non-GAAP Reconciliation – Free Cash Flow (1) “Free cash flow” is a non-GAAP financial measure that is reconciled in this schedule to the most directly comparable GAAP financial measures. This non-GAAP financial measure provides investors with greater visibility into cash flows provided by operating
Slide 19: Non-GAAP Reconciliation – FY23 Free Cash Flow Guidance
Non-GAAP Reconciliation – FY23 Free Cash Flow Guidance (1) “Free cash flow” is a non-GAAP financial measure that is reconciled in this schedule to the most directly comparable GAAP financial measures. This non-GAAP financial measure provides investors with greater visibility into cash flows provided
Slide 20: Bring On Tomorrow
BRING ON TOMORROVYS TAKING THE WORLD WHERE IT'S NEVER BEEN BEFORE. SAIC.
Science Applications International — Q4 FY2022 Earnings Presentation on 6ix